Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 11,236 | 0 | 0 | 0 | 0 |
| Gross Profit | 11,236 | N/A | N/A | N/A | N/A |
| Operating Expenses | 32,711 | 26,360 | -41,385 | 33,738 | 13,451 |
| Operating Income | -21,475 | -26,360 | 41,385 | -33,738 | -13,451 |
| Other Income | -1 | 16 | 179 | 185 | 319 |
| Pre-tax Income | -21,476 | -26,344 | 41,564 | -33,553 | -13,132 |
| Income Tax | 1,132 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -22,608 | -26,344 | 41,564 | -33,553 | -13,132 |
| Net Income | $-22,608 | $-26,344 | $41,564 | $-33,553 | $-13,132 |
| EPS Basic Total Ops | -3.80 | -4.80 | 6.20 | -6.00 | -2.60 |
| EPS Basic Continuous Ops | -3.84 | -4.68 | 7.57 | -5.92 | -2.59 |
| EPS Diluted Total Ops | -3.80 | -4.80 | 6.20 | -6.00 | -2.60 |
| EPS Diluted Continuous Ops | -3.84 | -4.68 | 7.57 | -5.92 | -2.59 |
| EBITDA(a) | $-21,444 | $-26,330 | $41,416 | $-33,683 | $-13,394 |